Northwest Biotherapeutics | NWBO - Assets


Northwest Biotherapeutics reported $30.61M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Agenus USD 233.89M 48.67M Sep/2025
AstraZeneca USD 114.07B 382M Dec/2025
Bristol-Myers Squibb USD 96.89B 2.21B Sep/2025
Celldex Therapeutics USD 648.44M 43.97M Sep/2025
Eisai JPY 1.49T 48.22B Dec/2025
Infinity Pharmaceuticals USD 21.23M 8.72M Jun/2023
Merck USD 129.55B 12.02B Sep/2025
Northwest Biotherapeutics USD 30.61M 1.06M Sep/2025
Pfizer USD 208.73B 2.64B Sep/2025
Plus Therapeutics USD 11.39M 1.89M Dec/2023
Roche Holding CHF 100.7B 5.94B Dec/2025